Clinical Trials Logo

Filter by:
NCT ID: NCT04650438 Withdrawn - Clinical trials for Creativity Performance in Healthy Subjects

Sleep and Creativity

Start date: April 2021
Phase: N/A
Study type: Interventional

Creativity is a complex neuro-psycho-philosophical phenomenon that is difficult to define. Neurocognitive models of creativity suggest that creativity is associated with the activity of a distributed, bilateral fronto-temporal and parietal network. Therefore, a modulation of frontal activity is necessary to allow a certain degree of "controlled disinhibition", which seems to be necessary for creative thinking. In addition, a modulation of the lower parietal lobe (IPL) might allow targeting the brain regions responsible for idea generation. This project will investigate the application of transcranial magnetic stimulation (TMS) with the intent of modulating creativity performance of healthy subjects. Resting state electroencephalography (EEG) that will be acquired pre- and post-TMS and participants' creative performance will be measured. Perspectives include a better understanding of the differences between high- and low-creativity groups, as measured by a creativity test battery, in their response to TMS. Additional perspectives are whether there are differences in creativity performance depending on the stimulation location.

NCT ID: NCT04708236 Withdrawn - COVID-19 Clinical Trials

A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related Pneumonia

Start date: April 2021
Phase: Phase 1/Phase 2
Study type: Interventional

Evaluate the safety and effect of ORTD-1 on COVID-19 related pneumonia.

NCT ID: NCT04721990 Withdrawn - Hearing Loss Clinical Trials

Subjective and Objective Performance With the SONNET2EAS

Start date: April 2021
Phase: N/A
Study type: Interventional

Purpose: The purpose of this study is to demonstrate the non-inferiority and new features of an external speech processor for cochlear implant recipients. Participants: This study seeks to enroll 15 cochlear implant recipients listening to previous technology. Procedures (methods): Subjects will be programmed and tested with old and new technology.

NCT ID: NCT04734860 Withdrawn - Covid19 Clinical Trials

Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms

Start date: April 2021
Phase: Phase 2
Study type: Interventional

This study investigates the safety, pharmacokinetic (PK) profile and efficacy of a single injection of COVI-AMG in outpatient adults with mild COVID-19 symptoms.

NCT ID: NCT04738175 Withdrawn - Covid19 Clinical Trials

Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) to Treat COVID-19

Start date: April 2021
Phase: Phase 1/Phase 2
Study type: Interventional

Subjects will receive a single injection of 40, 100, or 200 mg COVI-AMG or placebo via IV push.

NCT ID: NCT04771351 Withdrawn - Covid19 Clinical Trials

Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Hospitalized Adults With COVID-19

Start date: April 2021
Phase: Phase 2
Study type: Interventional

This is a placebo-controlled study to investigate the safety and efficacy of a single injection of COVI-AMG in inpatient adults with COVID-19.

NCT ID: NCT04807829 Withdrawn - Suicidal Ideation Clinical Trials

Adjunctive CB1 Agonist Nabilone in Inpatients With Active Suicidal Ideation

Start date: April 2021
Phase: Phase 2
Study type: Interventional

Suicide is a major crisis worldwide with rates projected to continue to increase. There is currently a dearth of novel pharmacologic treatment options for suicide available on the market. The endocannabinoid system has been recently shown to be associated with mood disorders including suicidality. The aim of the study is to determine whether treatment with Nabilone is capable of reducing suicidal ideation in adults after 3 days.

NCT ID: NCT04830878 Withdrawn - Clinical trials for Proliferative Vitreoretinopathy

Methotrexate For The Prevention and Treatment of Proliferative Vitreoretinopathy in Pediatric Patients

SIGHT
Start date: April 2021
Phase: Phase 1
Study type: Interventional

Rhegmatogenous retinal detachment (RRD) is a sight-threatening condition. Children with RRD usually present late with clinical features of longstanding RRD, specifically a serious condition named: proliferative vitreoretinopathy (PVR). Therefore, children with RRD often have poorer outcomes. The objective of this study is to investigate the efficacy and safety of methotrexate in the treatment and prevention of PVR. Methotrexate is a medication that has been used to treat inflammatory conditions in children and adults for a long time and it has been recently used to treat PVR in adults.

NCT ID: NCT04855266 Withdrawn - Iron-deficiency Clinical Trials

Iron Sucrose in Patients With Iron Deficiency and POTS

Start date: April 2021
Phase: Phase 2
Study type: Interventional

This study aims to investigate whether the treatment of non-anemic iron deficiency with intravenous iron sucrose will result in decreased symptom reporting and improved cardiovascular indices in patients with Postural Orthostatic Tachycardia syndrome (POTS).

NCT ID: NCT03814109 Withdrawn - Clinical trials for Arterial Hypertension

Efficacy and Safety of Leningrado Association in the Treatment of Hypertension

Start date: April 2022
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of Leningrado association on the treatment of hypertension.